Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols, P. Jeffrey Conn
Neurobiology of Disease (2013) Vol. 61, pp. 55-71
Open Access | Times Cited: 216

Showing 1-25 of 216 citing articles:

Trends in GPCR drug discovery: new agents, targets and indications
Alexander S. Hauser, Misty M. Attwood, Mathias Rask‐Andersen, et al.
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 829-842
Open Access | Times Cited: 2266
Dopamine receptors – IUPHAR Review 13
Jean‐Martin Beaulieu, Stefano Espinoza, Raul R. Gainetdinov
British Journal of Pharmacology (2014) Vol. 172, Iss. 1, pp. 1-23
Open Access | Times Cited: 454
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn, Craig W. Lindsley, Jens Meiler, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 692-708
Open Access | Times Cited: 239
Organization and functions of mGlu and GABAB receptor complexes
Jean‐Philippe Pin, Bernhard Bettler
Nature (2016) Vol. 540, Iss. 7631, pp. 60-68
Closed Access | Times Cited: 239
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 218
Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
Victor W. Pike
Current Medicinal Chemistry (2016) Vol. 23, Iss. 18, pp. 1818-1869
Open Access | Times Cited: 170
An Insight into GPCR and G-Proteins as Cancer Drivers
Preeti Kumari Chaudhary, Soochong Kim
Cells (2021) Vol. 10, Iss. 12, pp. 3288-3288
Open Access | Times Cited: 146
G Protein-Coupled Receptors: Dynamic Machines for Signaling Pain and Itch
Pierangelo Geppetti, Nicholas A. Veldhuis, TinaMarie Lieu, et al.
Neuron (2015) Vol. 88, Iss. 4, pp. 635-649
Open Access | Times Cited: 152
Harnessing Allostery: A Novel Approach to Drug Discovery
Shaoyong Lu, Shuai Li, Jian Zhang
Medicinal Research Reviews (2014) Vol. 34, Iss. 6, pp. 1242-1285
Closed Access | Times Cited: 138
Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs
Miles Congreve, Christine Oswald, Fiona H. Marshall
Trends in Pharmacological Sciences (2017) Vol. 38, Iss. 9, pp. 837-847
Closed Access | Times Cited: 110
Bile Acids: A Communication Channel in the Gut-Brain Axis
Vera F. Monteiro-Cardoso, Maria Corlianò, Roshni R. Singaraja
NeuroMolecular Medicine (2020) Vol. 23, Iss. 1, pp. 99-117
Closed Access | Times Cited: 110
G protein-coupled receptors as promising cancer targets
Ying Liu, Su An, Richard J. Ward, et al.
Cancer Letters (2016) Vol. 376, Iss. 2, pp. 226-239
Closed Access | Times Cited: 108
Druggable negative allosteric site of P2X3 receptors
Jin Wang, Yao Wang, Wen-Wen Cui, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 19, pp. 4939-4944
Open Access | Times Cited: 99
Discovery of new GPCR ligands to illuminate new biology
Bryan L. Roth, John J. Irwin, Brian K. Shoichet
Nature Chemical Biology (2017) Vol. 13, Iss. 11, pp. 1143-1151
Open Access | Times Cited: 94
G Protein-Coupled Receptors (GPCRs) in Alzheimer’s Disease: A Focus on BACE1 Related GPCRs
Juan Zhao, Yulin Deng, Zhaotan Jiang, et al.
Frontiers in Aging Neuroscience (2016) Vol. 8
Open Access | Times Cited: 89
Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation
Bas Brouwers, Edson Mendes de Oliveira, Maria Martí-Solano, et al.
Cell Reports (2021) Vol. 34, Iss. 12, pp. 108862-108862
Open Access | Times Cited: 58
Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases
Orkid Coskuner‐Weber, Ozan Mirzanli, Vladimir N. Uversky
Biophysical Reviews (2022) Vol. 14, Iss. 3, pp. 679-707
Open Access | Times Cited: 45
Allosteric Regulation of G-Protein-Coupled Receptors: From Diversity of Molecular Mechanisms to Multiple Allosteric Sites and Their Ligands
А. О. Шпаков
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6187-6187
Open Access | Times Cited: 26
Concerted conformational changes control metabotropic glutamate receptor activity
Nathalie Lecat-Guillet, Robert B. Quast, Hongkang Liu, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 24
Metabotropic glutamate receptors as drug targets: what's new?
Ferdinando Nicoletti, Valeria Bruno, Richard Teke Ngomba, et al.
Current Opinion in Pharmacology (2014) Vol. 20, pp. 89-94
Closed Access | Times Cited: 89
The muscarinic system, cognition and schizophrenia
Sean P. Carruthers, Caroline Gurvich, Susan L. Rossell
Neuroscience & Biobehavioral Reviews (2015) Vol. 55, pp. 393-402
Closed Access | Times Cited: 85
Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review
Paula Morales, Pilar Goya, Nadine Jagerovic, et al.
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 22-30
Open Access | Times Cited: 84
Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015)
Inder Pal Singh, Purvi Shah
Expert Opinion on Therapeutic Patents (2016) Vol. 27, Iss. 1, pp. 17-36
Closed Access | Times Cited: 83
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research
Nadhir Litim, Marc Morissette, Thérèse Di Paolo
Neuropharmacology (2016) Vol. 115, pp. 166-179
Closed Access | Times Cited: 78
Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury
David J. Loane, Bogdan A. Stoica, Flaubert Tchantchou, et al.
Neurotherapeutics (2014) Vol. 11, Iss. 4, pp. 857-869
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top